Page last updated: 2024-12-11

12-o-tetradeca-2,4,6,8-tetranoylphorbol-13-acetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

12-O-tetradeca-2,4,6,8-tetranoylphorbol-13-acetate (TPA) is a potent tumor promoter and a widely used tool in biomedical research. Here's a breakdown of its importance:

**What it is:**

* **Structure:** TPA is a diterpene ester, a complex organic molecule derived from plants.
* **Function:** It's a powerful activator of protein kinase C (PKC), a crucial enzyme involved in cell signaling pathways.

**Why it's important for research:**

* **Tumor Promotion:** TPA's ability to activate PKC is key to its role as a tumor promoter. It can:
* Induce cell proliferation (uncontrolled cell growth).
* Alter gene expression, leading to changes that contribute to cancer development.
* Trigger inflammation, a factor often associated with cancer.
* **Understanding Cancer Mechanisms:** Studying TPA's effects helps researchers understand how tumor promoters work at the molecular level. This knowledge is crucial for:
* Developing strategies to prevent cancer.
* Identifying new therapeutic targets for cancer treatment.
* **Model System for Studying Cell Signaling:** TPA is a valuable tool for investigating various cellular processes beyond cancer. It can be used to study:
* The role of PKC in diverse cellular functions.
* The mechanisms of inflammation.
* The regulation of gene expression.
* **Drug Development:** TPA has been investigated for its potential as a therapeutic agent in certain conditions, such as psoriasis and other skin disorders.

**However, it's important to note that:**

* **TPA is a potent compound and should only be handled by trained professionals in a laboratory setting.**
* **Its use in humans is strictly regulated due to its potential to promote cancer.**

Overall, 12-O-tetradeca-2,4,6,8-tetranoylphorbol-13-acetate (TPA) is a valuable tool in biomedical research due to its ability to activate PKC and its role in tumor promotion. It plays a significant role in furthering our understanding of cancer, cell signaling, and other biological processes.

Cross-References

ID SourceID
PubMed CID6437362
MeSH IDM0102536

Synonyms (12)

Synonym
12-o-tetradeca-2-cis,4-trans,6,8-tetraenoylphorbol-13-acetate
2,4,6,8-tetradecatetraenoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1h-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1ar-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalp
ti-8
brn 2319821
2,4,6,8-tetradecatetraenoic acid, (1ar,1bs,4ar,7as,7bs,8r,9r,9as)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1h-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester
5h-cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-3-hydroxymethyl-4a-alpha,7b-alpha,9-beta,9a-alpha-tetrahydroxy-1,1,6,8-alpha-tetramethyl-, 9a-acetate, 9-tetradeca-2,4,6,8-tetraenoate, (2z,4e)-
12-o-tetradeca-2,4,6,8-tetranoylphorbol-13-acetate
77550-14-2
64604-09-7
2,4,6,8-tetradecatetraenoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1h-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1ar-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aal
Q26840870
[(1s,2s,6r,10s,11r,13s,14r,15r)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] (2e,4e,6e,8e)-tetradeca-2,4,6,8-tetraenoate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (55.26)18.7374
1990's7 (18.42)18.2507
2000's9 (23.68)29.6817
2010's1 (2.63)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.45 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]